| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antimicrobial activity of new anti-Pseudomonas beta-lactam-beta-lactamase inhibitors against Pseudomonas aeruginosa respiratory isolates recovered during the study for Monitoring Antimicrobial Resistance Trends (SMART) program in France (2016–2022)
|
Zins, Charlie
|
|
|
55 |
4 |
p.
|
article
|
| 2 |
CV2 : Editorial board
|
|
|
|
55 |
4 |
p.
|
article
|
| 3 |
Diagnostic and clinical utility of [18F] FDG PET/CT in management of Staphylococcus aureus bacteremia
|
Okamura, Yui
|
|
|
55 |
4 |
p.
|
article
|
| 4 |
Early suPAR levels as a predictor of COVID-19 severity: A new tool for efficient patient triage
|
Nègre, Pauline
|
|
|
55 |
4 |
p.
|
article
|
| 5 |
HLA-A*03 may confer protection against long COVID through an enhanced immune response
|
Pons-Fuster, Eduardo
|
|
|
55 |
4 |
p.
|
article
|
| 6 |
Impact of an antibiotic stewardship programme in the emergency department of a secondary hospital
|
Martínez-de la Cruz, Paula
|
|
|
55 |
4 |
p.
|
article
|
| 7 |
Recommended gentamicin peak plasma levels rarely reached, even with recommended dosages
|
Perrier, Quentin
|
|
|
55 |
4 |
p.
|
article
|
| 8 |
The fragility of public health expertise and the challenges to overcome
|
Bourdillon, François
|
|
|
55 |
4 |
p.
|
article
|
| 9 |
The latest updates on the proper use of fluoroquinolones – Actualisation 2025 update by the SPILF and the GPIP
|
Vuotto, F.
|
|
|
55 |
4 |
p.
|
article
|
| 10 |
The safety profile of fluoroquinolones
|
Jonville-Béra, Annie-Pierre
|
|
|
55 |
4 |
p.
|
article
|
| 11 |
Usefulness of the GeneXpert MTB/RIF Ct for predicting tuberculosis infectiousness
|
Méchaï, F.
|
|
|
55 |
4 |
p.
|
article
|
Journal description